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Abstract
Background/Aims: In the current study we examined
if the multifunctional cytokine TGF-β1 mediated
glucose-evoked increases in connexin-43(Cx43)-
mediated intercellular communication in cells of the
human collecting duct (HCD). Methods: RT-PCR and
western blot analysis were used to confirm mRNA and
protein expression of TGF-β1 and Cx43 in HCD-cells.
The effect of TGF-β1 and high glucose (25mM) on
Cx43 protein expression, cytoskeletal organisation
and cell-cell communication was determined in the
presence/absence of TGF-β1 specific immuno-
neutralising antibodies. Functional cell-cell
communication was determined using Ca2+-
microfluorimetry. Results: At 24hrs, high glucose
(25mM) significantly increased Cx43 mRNA and
protein expression. Changes were mimicked by TGF-
β1 (2ng/ml) at low glucose (5mM). Both high glucose
and TGF-β1 mediated changes were completely
reversed by a pan-specific immuno-neutralising
antibody to TGF-β. Furthermore, high glucose-
evoked changes were inhibited by a TGF-β1-specific
monoclonal antibody. Mannitol (25mM), an osmotic
control for high glucose, failed to alter Cx43
expression. TGF-β1 evoked changes in Cx43
expression were biphasic. An early (4-8hr) transient
decrease in expression was followed by an increase
in protein expression (12-24hr). The decrease in Cx43
expression was paralleled by a transient
reorganisation of the actin cytoskeleton, whilst
increased Cx43 expression at 24hrs coincided with a
TGF-β1 specific increase in touch-evoked
transmission of Ca2+-signals between coupled cells.
Conclusions: High glucose evoked a TGF-β1
mediated increase in Cx43 expression and gap-
junction mediated cell-cell communication in HCD-
cells. These changes may maintain epithelial integrity
of the collecting duct following hyperglycaemic
assault as observed in diabetes.
Introduction
In renal epithelial, changes in osmolality initiate cell
volume regulatory processes, that restore cell volume,
and maintain both cell integrity and function. We recently
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showed that cells of the cortical collecting duct express
mechano-sensitive receptors that transduce alterations
in the physical environment into calcium-mediated cellular
changes that act to restore cell volume [1]. High glucose
and/or physical stimuli, generate rapid changes in [Ca2+]i
that up-regulate the functional expression of the epithelial
sodium channel (ENaC). We suggested that these
changes may underlie secondary hypertension associated
with hyperglycaemia and glucosuria, as seen in patients
with poorly managed diabetes [2].
Efficient and appropriate re-absorption of sodium
within the cortical collecting duct depends upon an
integrated response of the entire epithelium. The
co-ordination of cellular activity is therefore a pre-requisite
for the maintenance of cell homeostasis. In an in vitro
model of the human cortical collecting duct (HCD-cells)
Ca2+-transients evoked by mechanical stimulation
propogate between cells via connexin-43 (Cx43) -
mediated gap-junctions [1]. Gap-junctions allow for the
direct transfer of ions and small molecules between
coupled cells, enabling individual cells to monitor and adapt
their function in line with the activity of their immediate
neighbours. Although HCD-cells express several connexin
isoforms, Cx43 is the most abundantly expressed in the
collecting duct [3] and Cx43 expression increases further
in response to high glucose [1]. The variability of connexin
expression in response to high glucose has been described
in other cell types, including retinal [4, 5] and
cardiovascular tissue [6]. Loss of compensatory
mechanisms may result in overt complications associated
with diabetic nephropathy and end stage renal disease
and deregulation of Cx expression is associated in the
pathogenesis of some renal [7] and vascular diseases [8].
Whilst the question of how elevated glucose alters
connexin expression remains unanswered, glucose is
known to increase the activity of the multifunctional
cytokine Transforming Growth Factor-β (TGF-β) [9-14].
TGF-β is a ubiquitous cytokine that has a broad
spectrum of biological functions and actions in a variety
of cell types [15-17]. The prosclerotic properties of
TGF-β have been linked to excessive matrix deposition
in db/db diabetic mice [18] and in patients presenting with
nephropathy [19], and the cytokine is thought to play a
key role in the development and progression of diabetic
glomerulopathy [20-21]. Elevated TGF-β increases the
synthesis of fibronectin, laminin and collagen in both
glomerular mesangial cells and tubular cells [22].
Furthermore, TGF-β has been linked to epithelial
mesenchymal transition (EMT) [23], a process by which
epithelial cells into α-smooth muscle actin (SMA)-
positive, fibroblast-like cells. The phenotypic alterations
in renal proximal tubular cells that arise as a consequence
of TGF-β-induced EMT, can be reflected in a decreased
expression of inter-cellular adhesion molecules [24-25],
re-arrangement of actin microfilaments [24, 26-28] and
disassembly of tight junction complexes [29]. It has been
suggested that inter-cellular adhesion precedes and may
even be a prerequisite in forming fully functional gap
junctions [30]. In pancreatic β-cells we recently published
data demonstrating that one class of Ca2+-dependent
adhesion molecules, the catenins, bind to the cytoskeleton
[31] and facilitate gap junction assembly [30, 32-35].
It therefore seems likely that phenotypic alterations in
the cytoskeleton and thus cell shape may affect gap-
junction-mediated cell-to-cell interactions in some cell
types. To date however, there is no evidence for glucose-
evoked EMT in the cortical collecting duct and the effect
of TGF-β on gap-junction mediated cell-cell
communication has not yet been examined. In the current
study we have assessed temporal effects of TGF-β1 and
high glucose on Cx43 expression, cell architecture and




HCD cells were derived from normal human kidney
cortex and immortalized with SV-40 virus. Clones were selected
using the monoclonal antibody, Ab272, which specifically
recognizes collecting duct principal cells. HCD cells (passages
18-30) were maintained in DMEM/Hams F-12 medium (GIBCO,
Invitrogen), supplemented with 2% fetal calf serum (FCS),
glutamine (2mmol/L), 15mmol/L HEPES, transferrin (5μg/mL),
Na2SeO3 (5ng/mL), insulin (5μg/mL) and dexamethasone
(5x10-8M). Cells were grown at 37°C in a humidified atmosphere
of 5% CO2 in air. Prior to treatment, cells were cultured in DMEM/
Hams F-12 low glucose (5mM) for 48 hours. Basal (5mM)
glucose culture media was generated as described previously
[2]. For TGF-β1 experiments, cells were cultured in either low
(5mM) or high (25mM) glucose containing un-supplemented
DMEM/F12 for 48hr. Cells were treated with or without TGF-β1
(2ng/ml) and pre-incubated with either a TGF-β pan-specific
neutralising antibody (10µg/mL; R&D Systems Inc,
Minneapolis, USA) or a monoclonal TGF-β1-specific immuno-
neutralising antibody (10µg/mL; R&D Systems Inc,
Minneapolis, USA) for 1hr. In all experiments, cells were serum
starved overnight before agonist stimulation. For immuno-
cytochemistry and microfluorimetry experiments, cells were
seeded onto 3-Aminopropyltriethoxy-silane (APES)
(Sigma, Poole, UK) treated coverslips and used within 2 days
of plating.
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Analysis of mRNA expression
RNA was prepared from 80% confluent HCD cells by acid-
guanidinium extraction using a genelute mammalian total RNA
miniprep kit (Sigma) following the manufactures instructions.
Complementary DNA was synthesized by reverse transcription
using a Promega Reverse Transcription System following an
adapted method. Briefly, 1μg of total RNA and 0.5μg of random
hexamers, in a final volume of 11μL, were incubated at 70°C for
5min, and then allowed to cool slowly to 25°C. Primer extension
was then performed at 37°C for 60min following the addition of
1x (final concentration) reaction buffer, containing 50mmol/L
Tris-HCl (pH 8.3), 50mmol/L KCl, 10mmol/L MgCl2, 10mmol/L
dithiothreitol and 0.5mmol/L spermidine, 1mmol/L (final
concentration) of each dNTP, 40uL of rRNAsin ribonuclease
inhibitor and 15uL of AMV reverse transcriptase in a final
volume of 30μL. The RT mixture was heated to 95°C for 5min,
then 4°C for 5min. An aliquot of 4μL was used in subsequent
polymerase chain reaction (PCR) reactions.
PCR amplification of cDNAs
Amplification of specific cDNAs was carried out using
the primers listed in Table 1. PCR reactions (20μL) were set up
containing 1.5mmol/L MgCl2, 0.2mmol/L of each dNTP, 0.5μM
of each primer and 1U of Taq DNA polymerase (Promega).
Amplification of samples was performed using an initial
denaturation step of 95°C (5min) followed by either 35 cycles
(TGF-β1) and 30 cycles (Cx43) consisting of one minute of
denaturing at 95°C, one minute of annealing at the required
temperature and a one minute extension at 72°C. A final
elongation step of 72°C for seven minutes was included in all
PCR amplifications.
Analysis of protein expression
The preparation of cytosolic proteins and their
subsequent separation by gel electrophoresis and electro-
blotting onto Immobilon P membrane (Millipore, Watford,UK)
were as described previously [36]. Briefly proteins (5μg) were
separated by sodium dodecyl sulphate (SDS) polyacrylamide
gel electrophoresis (4.5% stacking gel, 7.5% or 10% resolving
gel) at 200v for 50min in electrophoresis buffer containing
25mmol/L Tris, 192mmol/L glycine and 0.1% (wt/vol) SDS.
Proteins were transferred onto Immobilin P membrane in transfer
buffer (25mmol/LTris, 192mmol/L glycine, 20% (vol/vol)
methanol) for 1hr at 100v; 4°C. Following protein transfer,
membranes were blocked in PBS-T (PBS plus 0.1% Tween-20)
containing 20% (wt/vol) nonfat milk powder (Marvel, Premier
Brands, Stafford, UK) for 1hr at 25°C and then washed with
PBS-T for 15min. Filters were analyzed with specific polyclonal
antibodies against human TGF-β1 (Santa Cruz), and anti-human
Cx43 (Santa Cruz) at a dilution of 1:500 and 1:200 respectively
in PBS-T. After three 10min washes in PBS-T, the membranes
were incubated with the secondary antibody (horseradish
peroxidase-conjugated) anti-rabbit (Cx43 diluted 1:30,000) and
anti-sheep (TGF-β1 diluted 1:40,000) in PBS-T (0.05%) for 60min
at 25°C followed by three 10min washes in PBS-T. Specific
proteins were detected using ECL detection reagent
chemiluminescence system (Amersham Biosciences) and were
visualized after exposure of membranes to X-ray film for 1-
10min. Control experiments were included where primary
antibody was omitted, and filters were exposed to secondary
antibody and ECL detection.
Immunocytochemistry
Cells were allowed to grow to 80% confluence on APES
treated coverslips and then fixed in 4% paraformaldehyde. Non-
specific binding was prevented by blocking for 1hr at 25°C in
PBS + 0.01% triton X-100 containing 10% normal goat serum.
Following three 10min washes with PBS, the nuclear stain DAPI
(4’,6-diamidino-2-phenylindole, dihydrochloride; 1mmol/L) was
added to each coverslip for 3min. After washing with PBS
(3x5min), cells were incubated with the cytoskeletal stain TRITC-
conjugated-Phalloidin (Sigma) diluted at 1:100 in PBS
supplemented with 0.01% Triton X-100 for 1 hour at 25°C. After
1hr, cells were washed 3x10min and coverslips mounted in
citifluor (glycerol/PBS solution: Agar Scientific) on glass slides.
Single-cell microfluorimetry
HCD cells seeded and grown overnight on APES-coated
coverslips were loaded for 30min at 37°C with 2.5µM of the Ca2+
fluorophore fura-2/AM (Sigma). Coverslips were washed and
placed in a steel chamber, the volume of which was approximately
500µl. A single 22mm coverslip formed the base of the chamber,
which was mounted into a heating platform on the stage of an
Axiovert 200 Research Inverted microscope (Carl Zeiss, Welwyn
Garden City, UK). All experiments were carried out at 37°C using
unsupplemented DMEM-Ham’s F-12 medium as the standard
extracellular medium. Cells were illuminated alternatively at 340
and 380nm using a Metaflour imaging workbench (Universal
Imaging, Marlow, Bucks, UK). Emitted light was filtered by
using a 510nm long-pass barrier filter and detected using a
Cool Snap HQ CCD camera (Roper Scientific). Changes in the
emission intensity of fura-2 expressed as a ratio of dual
excitation were used as an indicator of changes in [Ca2+]i with
the use of established procedures. Data were collected at 3s
intervals for multiple regions of interest in any one field of
Table 1. Polymerase chain reaction (PCR) primers used to amplify TGF-β1 and Cx43
mRNA. F = forward primer, R = reverse primer.
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view. All records have been corrected for background
fluorescence (determined from cell-free coverslip).
Mechanical stimulation of HCD cells
Individual cells within a cluster (6-12 cells/cluster) of fura-
2-loaded cells were stimulated via touch using a femtotip
electrode delivery system (Eppendorf, Hamburg, Germany).
Maintained fura-2 fluorescence confirmed the integrity of the
cell membrane.
Transmission velocity experiments
HCD cells were seeded and grown to 50% confluence on
APES-coated coverslips in the previously described standard
culture medium. After an overnight period of serum starvation,
the medium was then removed and changed to a test medium
containing 5 or 25 mmol/l glucose plus/minus TGF-β1 and/or
TGF-β1 specific neutralising antibody. After a 48hr exposure to
each test medium, individual cells within a cluster (6-12 cells/
cluster) of fura-2-loaded cells were stimulated via touch using
a femtotip electrode delivery system. The rate of transmission
of a touch-evoked Ca2+ signal between individual HCD cells
was assessed. Maintained fura-2 fluorescence confirmed the
integrity of the cell membrane.
Data Analysis
Autoradiographs were quantified by densitometry
(TotalLab 2003). Statistical analysis of data was performed using
a one-way ANOVA test with a Tukey’s Multiple Comparison
Fig. 1. Expression of TGF-β1 and Cx43 mRNA and protein in
HCD-cells. Panels A and C represent RT-PCR analyses using
primers specific for human TGF-β1 and Cx43. PCR products of
341bp and 597bp were observed in two separate RNA
preparations (1 and 2) corresponding to mRNA expression for
TGF-β1 and Cx43 in HCD cells. Negative controls included
both water and samples in which AMV enzyme had been omitted
from the reverse transcription reaction (data not shown).
Western blot analyses of HCD cell lysates (panels B and D,
5μg protein/lane) using an antibody against human TGF-β1
(panel B) and Cx43 (panel D) confirmed the presence of the
protein in HCD cells. A protein band of approximately 45kDa
(TGF-β1), and 43kDa (Cx43) was detected. Controls included
TGF-β1 and Cx43 antibody pre-absorbed with a 10-fold excess
of immunizing peptide. (Data not shown).
Fig. 2. Cx43 mRNA and protein expression are glucose
dependent. Panel A represents RT-PCR analyses using primers
specific for human Cx43. Exposure of HCD cells to high (25mM)
glucose increased Cx43 mRNA at both 24 (panel A, band 2) and
48hrs (panel A, band 3) compared to low glucose control (5mM;
panel A, band 1). Negative controls included both water and
samples in which AMV enzyme had been omitted from the
reverse transcription reaction (data not shown). Blots (n=3)
were quantified by densitometry and expressed as a % of low
glucose control (panel B). Differences between control and
each test condition was compared statistically where, **
P<0.01. Western blot analyses of HCD cell lysates (panels C
and D, 5μg protein/lane) using an antibody against Cx43,
confirmed that exposure to high (25mM) glucose increased
Cx43 protein expression at both 24 (panel C, band 2) and 48hrs
(panel C, band 3) compared to low glucose control (5mM; panel
C, band 1). Blots (n=3) were quantified by densitometry and
expressed as a % of low glucose control (5mM; panel D).
Differences between control and each test condition was
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Fig. 3. Changes in osmolarity do not alter Cx43 expression.
Western blot analyses of HCD cell lysates (5μg protein/lane)
using an antibody against Cx43, confirmed that exposure to
high (25mM) glucose increased Cx43 protein expression at 48hrs
compared to low glucose control (panel A; band 2) compared
to low glucose control (5mM; panel A, band 1). Equimolar
concentrations of mannitol (25mM), as an osmotic control, failed
to alter Cx43 expression over the same time period (panel A;
band 3). Blots (n=3) were quantified by densitometry and
expressed as a % of low glucose control (5mM; panel B).
Differences was compared statistically where, ** P<0.01.
Fig. 4. TGF-β1 mediates the effects of high glucose on Cx-43
expression. HCD cells were grown (48hr) in either low glucose
(5mM; solid columns) +/- TGF-β1 (2ng/mL), or high glucose
(25mM; hatched columns), either in the presence or absence of
a pan-specific (PAN) or monoclonal TGF-β1-specific (MONO)
neutralising antibody. The expression of Cx43 was determined
by immunoblotting. Upper panel (A) is a representative
immunoblot showing changes in Cx43 expression under each
of the conditions described in panel B. Blots (n=3) were
quantified by densitometry and expressed as a % of low glucose
control (5mM; panel B). Differences between control and each
test condition was compared statistically where, ** P<0.01,
*** P< 0.001.
post-test. Data are expressed as arithmetic mean±SEM and n
denotes the number of experiments and P<0.05 signifies
statistical significance.
Results
Expression of TGF-β1 and Cx43 in HCD cells
RT-PCR analysis of two RNA preparations from
HCD cells revealed PCR products representative of
TGF-β1 and Cx43 mRNA (figure 1A and C respectively).
To confirm that the mRNA was appropriately translated,
protein expression was determined by western blotting
(figures 1B and D). Western blot analyses revealed bands
at approximately 45kDa and 43kDa representative of
those expected for TGF-β1 and Cx43.
High-glucose-evoked up-regulation of Cx43
expression
To examine the effect of glucose on Cx43
expression, HCD cells were incubated in high glucose
(25mM) for 24hr and 48hr. The expression of Cx43 was
assessed by RT-PCR and western blot analysis.
High glucose (25mM) increased Cx43 mRNA expression
(figure 2A) to 146.2±8.5% and 186.8±7.8% of low
glucose control (5mM) at 24hr and 48hr respectively
(figure 2B; P<0.01, n=3). Western blot analysis confirmed
a corresponding increase in Cx43 protein expression
(figure 2C) to 163±11% and 203±12% (P<0.01, n=3) of
low glucose control (5mM: figure 2D) at 24hr and 48hr
respectively. Mannitol (25mM) was used as a control for
the osmotic effects of high glucose and increased Cx43
expression at 48hr by only 29±1.4% of the glucose-evoked
change seen under identical experimental conditions (see
figure 3, P=NS, n=3).
Glucose induced Cx43 expression is mediated by
TGF-β1
To determine the role of TGF-β1 in mediating the
glucose-evoked increase in Cx43 expression we examined
the effect of TGF-β and TGF-β1 specific immuno-








neutralising antibodies on glucose-evoked changes in
Cx43 expression (Figure 4, hatched columns). At 48hrs,
high glucose (25mM) increased Cx43 expression to
169±4.3% as compared to low glucose (5mM) control
(P<0.01). Co-incubation with either a pan-specific or
TGF-β1-specific immuno-neutralising antibody negated
the effect of high glucose (79±12.4%; P<0.001 and
83±11.6%; P<0.01 respectively as compared to low
glucose (5mM) control; n=3).
The effect of exogenous application of TGF-β1 (2ng/
mL) +/- pan-specific TGF-β immuno-neutralising antibody
was also examined (Figure 4, solid columns). HCD cells
were incubated for 48hrs at low glucose (5mM) +/-
TGF-β neutralising antibody. TGF-β1 (2ng/ml) induced a
51% increase in Cx43 expression to 151±8.9%, whilst
co-application with the pan-specific neutralising antibody
reduced Cx43 expression to 98±12.7% as compared to
control at low glucose. The effect of mannitol (25mM)
was similar to the low glucose (5mM) control (P=NS).
TGF-β1 has a biphasic effect on Cx43 expression
in HCD-cells
In other cell systems, the effects of TGF-β are
reportedly rapid in onset. To resolve temporal effects of
exogenous TGF-β1 we examined the effects of the
cytokine (2ng/mL) on Cx43 expression at 4, 6, 8, 12 and
24hrs. Over this time course, TGF-β1 evoked a biphasic
response on protein expression. At 4, 6 and 8hrs
Fig. 5. TGF-β1 exerts a biphasic effect on Cx43 protein expression. HCD cells were grown in low glucose
(5mM) plus TGF-β1 (2ng/ml) at 4, 6, 8, 12, and 24hrs and Cx43 expression determined by immunoblotting.
Upper panel (A) is a representative immunoblot showing Cx43 expression at each of the time intervals
described in panel B. Blots (n=3) were quantified by densitometry and expressed as a % of low glucose
control (5mM; panel B). Differences between control and each time interval was compared statistically,
where * P<0.05. In panel C, TRITC-conjugated phalloidin was used to visualise filamentous actin.
In control low glucose (5mM) the actin cytoskeleton appears as loosely associated filaments organised
throughout the cell interior (figure 5Ci). TGF-β1 (2ng/mL) stimulated the formation of peripheral stress
fibres at 1 and 4hrs (figure 5Cii and iii respectively). These were prevented by co-incubation with the
TGF-β1-specific immuno-neutralising antibody (figure 5Civ; 4hr incubation). At 24 hours, cytoskeletal
organisation was restored to the control pattern (figure 5Cv). The effect of un-conjugated phalloidin (10µg/
mL) +/- TGF-β1 (2ng/mL) on Cx43 expression in low (5mM) glucose at 4 and 6hrs is examined in panel D and
E, where D shows a representative immunoblot of Cx43 expression described in E (n=3). Stabilisation of the






Hills/Bland/Bennett/Ronco/SquiresCell Physiol Biochem 2009;24:177-186
183
TGF-β1 reduced Cx43 expression by 56±1.7%, 32±8.8%
and 41±3.9% respectively, as compared to a low glucose
(5mM) control (figure 5; P<0.05 in each case). At 24hrs
Cx43 expression had significantly increased compared
to control (152±17.7%, P<0.05, figure 5). Incubation of
HCD cells with vehicle had no effect on Cx43 expression
(data not shown).
Recent reports have indicated that TGF-β1 induces
very rapid actin polymerization and formation of actin
stress fibres in various cell models [37, 38]. To examine
the potential role of cytoskeletal re-arrangement on the
temporal variability of Cx43 expression we performed a
parallel series of experiments to assess the effects of the
cytokine on the filamentous actin. In figure 5C(i),
phalloidin staining detected a loose cytoplasmic
organisation of actin at low (5mM) glucose. Addition of
TGF-β1 (2ng/mL) evoked a general increase in actin
stress fibres around the periphery of the cells at 1 and
4hrs (figure 5Cii and iii respectively). The appearance of
TGF-β1-induced peripheral stress fibres was prevented
by co-incubation with the TGF-β1-specific immuno-
neutralising antibody (figure 5Civ; 4hr incubation). At 24
hours, cytoskeletal organisation was restored to a low
glucose (5mM) non-stimulated pattern (figure 5Cv).
To confirm that the transient reduction in TGF-β1-induced
Cx43 expression was correlated to cytoskeletal re-
organistaion, cells were incubated at low (5mM) glucose
plus or minus phalloidin (10µg/mL) in order to stabilise
the actin cytoskeleton (figure 5D and E). Neither phalloidin
alone at 6hrs (93±8%, figure 5E; C(6hr)), nor TGF-β1
(2ng/mL) plus phalloidin at 4 and 6hr altered Cx43
expression compared to low glucose control (88±5% and
94±10% respectively, P=NS). DMSO (0.01%) vehicle
had no effect on Cx43 expression or cytoskeletal
organisation (data not shown).
TGF-β1 mediates glucose-evoked increases in
inter-cellular communication
We have previously shown that glucose-evoked in-
creases in Cx43 expression are matched to an increase
in gap-junction-mediated intercellular communication
(GJIC [1]). In this earlier study we demonstrated that
HCD-cells express the mechano-sensitive transient
receptor potential channel (TRPV4), evoking transient,
propagating Ca2+-signals in response to touch. To
confirm that glucose induced cell-to-cell coupling is
TGF-β1 dependent, Ca2+-microfluorimetry was used to
assess the effect of high glucose (25mM) or TGF-β1
(2ng/mL), either alone or co-applied with a TGF-β1 spe-
cific neutralising antibody, on the transmission of mechani-
cally evoked Ca2+-signals between coupled HCD cell clus-
ters (figure 6). Following 48hr incubation, the velocity of
touch-evoked Ca2+signals between adjacent cells was
elevated by both TGF-β1 (145±14.9%) and high glucose
(214±4.5%; P<0.001, see figure 6), as compared with
that of cells cultured in low (5mM) glucose. The depend-
ence of the glucose-evoked response on TGF-β1 was
confirmed using co-incubation of the TGF-β1-specific
antibody, which returned both TGF-β1 stimulated and high
glucose-stimulated increases in GJIC back to control, low
Fig. 6. Glucose-evoked increases in
cell-cell communication are TGF-β1-
dependent. HCD cells were grown (48hr)
in either low glucose (5mM; solid
columns) +/- TGF-β1 (2ng/mL), or high
glucose (25mM; hatched columns),
either in the presence or absence of a
TGF-β1-specific (MONO) neutralising
antibody. Individual Fura-2-loaded cells
were mechanically stimulated and the
speed of transmission (µm/s) of touch-
evoked Ca2+-transient between coupled
cells was determined (panel B; region of
interest (ROI) 1-4 overlays 4 individual
cells within a coupled cell cluster). The
time point for the initial rise in [Ca2+]i for
each ROI was determined and related to the distance between individual cells (panel C). Mean data±SEM (n=4 separate experiments
for each treatment, are shown in panel A). High glucose (25mM; hatched columns) significantly increases the transmission of
Ca2+-transients between cells (*** P< 0.001), whilst co-incubation with TGF-β1-specific neutralising antibody negates the
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glucose, levels (107±8% and 122±10%; P<0.01). These
data suggest that both increased Cx43 expression and
increased cell-to-cell coupling exhibited by HCD cells in
response to high glucose is a TGF-β1 dependent proc-
ess.
Discussion
Diabetic nephropathy is a leading worldwide cause
of chronic kidney disease (CKD) and end-stage renal
disease. Elevated glucose is a major contributing factor
in the development of diabetic nephropathy [39, 40], and
in the kidney it has been suggested that glucose mediates
many of its cellular effects via the Transforming Growth
Factor-beta-1 (TGF-β1) [10-13]. A cytokine with
powerful fibrogenetic effects, TGF-β is up-regulated in
models of diabetes and diabetic nephropathy [20, 21, 41].
Abnormalities in TGF-β1 signalling have been discovered
in a wide variety of disorders, including autoimmune
diseases, malignancies, and chronic renal disease with
increased receptor expression having been described in
experimental renal disease models including membranous
nephropathy, obstructive nephropathy, and diabetic
nephropathy.
In the current study we have examined the possibility
that TGF-β1 mediates glucose-evoked increases in Cx43
and cell-to-cell communication in a model system of the
human collecting duct. Confirming previous data [1] we
have demonstrated that HCD cells express both Cx43
and TGF-β1 and that the expression of both mRNA and
protein is glucose-dependant, significantly increasing over
24-48hr in 25mM glucose. The effect of high glucose
was not osmotically-dependent as equimolar mannitol
failed to alter Cx43 expression. Conversely, immuno-
neutralising TGF-β, and more specifically the TGF-β1
isoform, prevented glucose-evoked changes in Cx43
expression. TGF-β1 significantly increased Cx43
expression at 24hrs, but the effect was biphasic, being
preceded by an initial short-term (<8hrs), transient
decrease in protein expression.
The localisation, activity and trafficking of membrane
bound proteins is mediated through interactions with actin,
actin-binding proteins and/or scaffolding proteins
[reviewed in 42]. Therefore, alterations in the architectural
framework of cells would have clear repercussions for
the clustering, retention and activity of membrane bound
cell adhesion and coupling proteins. Consequently, it could
be argued that changes in the arrangement of the actin
cytoskeleton could alter gap junction expression and
function. Interestingly, in the current study, the short-term
TGF-β1-induced loss of Cx43-expression was matched
temporally to a rapid, but transient re-organisation of the
actin cytoskeleton into peripheral stress fibres.
These changes were reversible over time (24hrs) and
could be blocked by TGF-β1-specific neutralising antibody.
Changes in TGF-β expression have been associated with
numerous phenotypic changes including re-organisation
of the actin cytoskeleton in both proximal tubular epithelial
cells [24, 25] and mesangial cells [27]. TGF-β-induced
changes in actin, and thus cell shape, could have dramatic
implications for cell architecture, protein expression, cell-
to-cell communication and ultimately epithelial function.
Previous studies have shown that TGF-β remodels actin
microfilaments in proximal tubular cells, causing
disassembly of tight junction complexes [29], and the
present study suggests that TGF-β1 also affects Cx43
expression. Early TGF-β1 induced architectural changes
serve to strengthen the cell membrane, but result in a
transient decrease in Cx43-mediated cell contact. Whilst
initial TGF-β1-induced down-regulation of Cx-43
expression may reflect a latency period involving re-
arrangement of the actin cytoskeleton, it seems likely that
up-regulation of Cx43 at 24 and 48hrs reflects stabilisation
of the cytoskeleton and recovery, allowing restoration and
enhancement of protein expression, in the continuous
presence of the cytokine. The dependence of the transient
loss in Cx43 expression on changes to cytosolic
filamentous actin was confirmed using phalloidin to
stabilise the actin cytoskeleton. In these experiments,
where phalloidin alone and vehicle had no effect on protein
expression, the previous short-term loss in TGF-β1-
induced Cx43 expression was ablated.
Cx43 represents the major gap-junction connexin in
the nephron [3]. Consequently, up-regulation of Cx43
expression would be expected to correlate to an increase
in GIJC. Previous data from our laboratory have
demonstrated the expression of mechano-sensitive
TRPV4 in HCD cells [1]. By physically touching an
individual fura-2-load HCD cell we are able to elicit an
increase in [Ca2+]i. This Ca
2+-transient then flows through
Cx-mediated gap junctions to elicit a synchronised
response in neighbouring cells. By measuring the time of
onset of our touch-evoked rises in [Ca2+]i and measuring
the distance between coupled cells we can determine
the transmission speed of direct cell-to-cell
communication. Through the use of exogenous TGF-β1
and TGF-β1-specific neutralising antibodies our data
suggest that high glucose significantly increases cell-cell
communication via a TGF-β1-specific mechanism.
Hills/Bland/Bennett/Ronco/SquiresCell Physiol Biochem 2009;24:177-186
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